Poland· PL-100363231
Toralis
A lisinopril und diuretika product containing lisinoprilum + torasemidum, registered in Poland by Aflofarm Farmacja Polska Sp. z o.o.. The same ATC class is registered in 11 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Lisinopril und diuretika is registered in 11 of 19 countries.
Countries holding a registration under ATC C09BA03 (lisinopril und diuretika), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Lisinopril und diuretika · ATC C09BA03
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Lisinoprilum + Torasemidum
- Manufacturer
- Aflofarm Farmacja Polska Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- C09BA03
- ATC class
- Lisinopril und Diuretika
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 3
- gtin05909991362058
- gtin05909991362065
- gtin05909991362072
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
67 interactions on record for lisinopril und diuretika.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Lisinopril und diuretika · interactions on record
67 records
67 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Lisinopril und diuretika in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Czechia · Tolirasim
- Lithuania · Tolirasim
- Slovakia · Lisemid
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/891ce94e-cb70-43ec-90ab-d8e57acb76f1 GET /v1/drugs/891ce94e-cb70-43ec-90ab-d8e57acb76f1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki",
"source": "urpl",
"strength": "10 mg + 10 mg",
"packaging": "05909991362058 ¦ Rp ¦ 126703\n30 tabl.\n05909991362065 ¦ Rp ¦ 126704\n60 tabl.\n05909991362072 ¦ Rp ¦ 126705\n90 tabl.",
"substance": "Lisinoprilum 10 mg + Torasemidum 10 mg",
"common_name": "Lisinoprilum + Torasemidum",
"pl_product_id": "100363231",
"pozwolenie_nr": "24541",
"auth_procedure": "DCP",
"authorisation_validity": "Bezterminowe"
}See everything about lisinopril und diuretika.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.